The AD/PD™ Conference offers a high quality scientific program covering the most recent research, clinical trials, developments, and treatments in Alzheimer’s and Parkinson’s, with emphasis on overlaps and congruent results among AD. This provides participants with unparalleled and powerful insights into distinct neurodegenerative diseases in one setting to examine their similarities and differences.
Science and education are the main forces behind AD/PD™ conferences and participants agree that the quality of the content and the educational value are what set it apart from other events in the field. In the CME Participant Evaluation Form 96% state that the event contributed to their professional development, while almost 97% agree that the quality of the speakers was excellent.
A unique conference that provides a world class platform for clinical investigators and basic scientists to present, discuss and trade expertise on a broad range of themes and topics, AD/PD™ has gone from strength to strength attracting over 3,800 participants from 75 countries and over 2,200 abstracts in 2019.
These Cookies are necessary for the Services to function properly and cannot be disabled. They are usually only set, in response to actions made by you, enabling functions like navigation, or setting preferences. These Cookies do not store information about you that will be used for other purposes.
These Cookies are for internal use only. They help us to secure and maintain our Services, and to remember your preferences for tools found on the Services. They are also used for gathering analytics data on how you interact with our Services and the improvement performance of the site accordingly. If you do not allow these Cookies, we will not know when you have visited our site.